GANX Stock Price & Quote | Gain Therapeutics, Inc. Common Stock | FurlPay
Gain Therapeutics, Inc. Common Stock (GANX) Stock Price
Gain Therapeutics, Inc. Common Stock (NASDAQ: GANX) last traded at $2.01, up 1.26% on the session. The quote above updates while this page is open; the figures below are drawn from Gain Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Gain Therapeutics, Inc. Common Stock (GANX) company overview
Gain Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker GANX. Its market capitalisation is $87.51 million.
GANX valuation
Valuation measures for Gain Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$87.51M
Enterprise value
$78.55M
Price / book
7.75
Beta
1.73
GANX financials
Trailing-twelve-month figures tagged in Gain Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
Net income (TTM)
-$20.11M
EPS (TTM)
-$0.500
Return on equity
-178.06%
Cash
$13.08M
GANX trading statistics
Range and volume for GANX over the past 52 weeks.
52-week high
$4.34
52-week low
$1.53
Volume
243.2K
Average volume
862.7K
Previous close
$1.98
Gain Therapeutics, Inc. Common Stock (GANX) FAQs
What is the GANX stock price today?
Gain Therapeutics, Inc. Common Stock (GANX) last traded at $2.00, up 1.26% on the session. FurlPay quotes GANX from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is GANX listed on?
Gain Therapeutics, Inc. Common Stock is listed on NASDAQ under the ticker symbol GANX.
What is Gain Therapeutics, Inc. Common Stock's market cap?
Gain Therapeutics, Inc. Common Stock has a market capitalisation of $87.51 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is GANX's 52-week range?
Over the past 52 weeks GANX has traded between $1.53 and $4.34.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001819411), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.